ETF · holdings as filed 2026-05-31

What's inside FPHAX?

Select Pharmaceuticals Portfolio
Holdings
48
positions in the fund
Top 10
72%
of fund assets
Expense ratio
0.67%
net, per year
Fund size
$2B
total net assets
Sectors
Top holdings — Health Care
Your 10 largest positions in this sector
1
L
LLYELI LILLY & CO
28.20%
2
G
GSKGSK PLC-SPON ADR
8.00%
3
V
VTRSVIATRIS INC
5.34%
4
M
MRKMERCK & CO. INC.
4.65%
5
L
LEGNLEGEND BIOTECH CORP-ADR
4.44%
6
A
AZNASTRAZENECA PLC
4.14%
7
E
ELANELANCO ANIMAL HEALTH INC
4.07%
8
J
JAZZJAZZ PHARMACEUTICALS PLC
4.01%
9
G
GILDGILEAD SCIENCES INC
3.89%
10
J
JNJJOHNSON & JOHNSON
3.70%
Geography
Top holdings — United States
Your 10 largest positions in this country
1
L
LLYELI LILLY & CO
28.20%
2
V
VTRSVIATRIS INC
5.34%
3
M
MRKMERCK & CO. INC.
4.65%
4
L
LEGNLEGEND BIOTECH CORP-ADR
4.44%
5
E
ELANELANCO ANIMAL HEALTH INC
4.07%
6
G
GILDGILEAD SCIENCES INC
3.89%
7
J
JNJJOHNSON & JOHNSON
3.70%
8
M
MRNAMODERNA INC
1.54%
9
N
NTLAINTELLIA THERAPEUTICS INC
1.16%
10
B
BEAMBEAM THERAPEUTICS INC
1.08%
Geography reflects each issuer's registered business address per SEC EDGAR filings where available, falling back to the exchange or listing where no SEC filing exists — not necessarily where a company's stock is primarily listed (e.g. TSMC is classified as Taiwan even though its ADR trades on the NYSE).
Hold FPHAX alongside other funds? See your combined true holdings, overlap, and blended fees — free, no signup.
Unwrap your portfolio →
Data source: official SEC Form N-PORT filings (as of 2026-05-31); expense ratio from SEC prospectus (risk/return) filings. Fund holdings are disclosed quarterly and may reflect a 60-day reporting delay.
Informational and educational only — not investment advice.